[1] Karlsson I, Antonsson L, Shi Y, et al. Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype[J]. J Virol, 2004, 78(21): 11807-15. [2] Emingil G, Atilla G, Huseyinov A. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis[J]. J Clin Periodontol, 2004, 31(10): 829-34. [3] http://www.ncbi.nlm.nih. gov/entrez/query. fcgi? cmd=Retrieve&db=Nucleotide&list_uids=39771663&dopt=GenBank. [4] http://www.ncbi.nlm.nih.gov/entrez/query. fcgi?cmd=Retrieve&db=Nucleotide&list_uids=32698439&dopt=GenBank. [5] Petry K, Boulleme A, Pousset F, et al. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis[J]. Pathol Biol, 2000, 48(1): 47-53. [6] Liu YY, Gordienko I, Mathias A, et al. Expression of an anti-CD3single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line[J]. Protein Expr Purif, 2000, 19(2): 304-11. [7] Thompson J, Stavrou S, Weetall M, et al. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion[J]. Protein Eng, 2001, 14(12): 1035-41. [8] Urieto JO, Liu T, Black JH, et al. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials[J]. Protein Expr Purif, 2004, 33(1): 123-33. [9] Foss F, Bacha P, Osann K, et al. Biological correlates of acute hypersensitivity events with DAB(389) IL-2 (denileukin diftitox, ONTAK)in cutaneous T-cell lymphoma: decreased freguency and severity in steroid premedication[J]. Clin Lymphoma, 2001, 1: 298-302. |